{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:14:55Z","timestamp":1790226895500,"version":"4.1.0"},"reference-count":56,"publisher":"American Association for the Advancement of Science (AAAS)","funder":[{"name":"Guangxi Science and Technology Key Research and Development Program","award":["No. AB16450012"],"award-info":[{"award-number":["No. AB16450012"]}]}],"content-domain":{"domain":["spj.science.org"],"crossmark-restriction":true},"short-container-title":["Research"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:p>Breast cancer (BC) often spreads to bones, leading to bone metastasis (BM). Current targeted therapies have limited effectiveness in the treatment of this condition. Osteoclasts, which contribute to bone destruction, are crucial in supporting tumor cell growth in the bones. Breast cancer bone metastasis (BCBM) treatments have limited efficacy and can cause adverse effects. Ononin exhibits anticancer properties against various cancers. The study examined the impact of ononin on the BCBM and the signaling pathways involved. Our study utilized a variety of experimental techniques, including cell viability assays, colony formation assays, wound-healing assays, Transwell migration assays, Western blot analysis, and tartrate-resistant acid phosphatase (TRAP) staining. We examined the effects of ononin on osteoclastogenesis induced in MDA-MB-231 conditioned medium- and RANKL-treated RAW 264.7 cells. In a mouse model of BCBM, ononin reduced tumor-induced bone destruction. Ononin treatment effectively inhibited proliferation and colony formation and reduced the metastatic capabilities of MDA-MB-231 cells by suppressing cell adhesion, invasiveness, and motility and reversing epithelial\u2013mesenchymal transition (EMT) markers. Ononin markedly suppressed osteoclast formation and osteolysis-associated factors in MDA-MB-231 cells, as well as blocked the activation of the mitogen-activated protein kinase (MAPK) pathway in RAW 264.7 cells. Ononin treatment down-regulated the phosphorylation of MAPK signaling pathways, as confirmed using MAPK agonists or inhibitors. Ononin treatment had no adverse effects on the organ function. Our findings suggest that ononin has therapeutic potential as a BCBM treatment by targeting the MAPK pathway.<\/jats:p>","DOI":"10.34133\/research.0553","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T15:47:21Z","timestamp":1733845641000},"update-policy":"https:\/\/doi.org\/10.34133\/aaas_crossmark_01","source":"Crossref","is-referenced-by-count":36,"title":["Ononin Inhibits Tumor Bone Metastasis and Osteoclastogenesis By Targeting Mitogen-Activated Protein Kinase Pathway in Breast Cancer"],"prefix":"10.34133","volume":"7","author":[{"given":"Kumar","family":"Ganesan","sequence":"first","affiliation":[{"name":"School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sui","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Du","sequence":"additional","affiliation":[{"name":"College of Food Science, South China Agricultural University, Guangzhou, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Gao","sequence":"additional","affiliation":[{"name":"Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3206-782X","authenticated-orcid":true,"given":"Hailin","family":"Tang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.105609","article-title":"Isoliquiritigenin-infused electrospun nanofiber inhibits breast cancer proliferation and invasion through downregulation of PI3K\/Akt\/mTOR and MMP2\/9 pathways","volume":"96","author":"Ganesan K","year":"2024","unstructured":"Ganesan K , Gao F , Zheng C , Xu C , Tang H , Sui Y , Xie C , Chen J . Isoliquiritigenin-infused electrospun nanofiber inhibits breast cancer proliferation and invasion through downregulation of PI3K\/Akt\/mTOR and MMP2\/9 pathways. J Drug Deliv Sci Technol. 2024;96:Article 105609.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-010-0935-7","article-title":"Should bisphosphonates be utilized in the adjuvant setting for breast cancer?","volume":"122","author":"Lipton A","year":"2010","unstructured":"Lipton A . Should bisphosphonates be utilized in the adjuvant setting for breast cancer? Breast Cancer Res Treat. 2010;122(3):627\u2013636.","journal-title":"Breast Cancer Res Treat"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111037","article-title":"Cryoprotective isoliquiritigenin-zein phosphatidylcholine nanoparticles inhibits breast cancer-bone metastasis by targeting JAK-STAT signaling pathways","volume":"396","author":"Ganesan K","year":"2024","unstructured":"Ganesan K , Xu C , Xie C , Sui Y , Zheng C , Gao F , Chen J . Cryoprotective isoliquiritigenin-zein phosphatidylcholine nanoparticles inhibits breast cancer-bone metastasis by targeting JAK-STAT signaling pathways. Chem Biol Interact. 2024;396:Article 111037.","journal-title":"Chem Biol Interact"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3055"},{"issue":"7","key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1021\/acsnano.9b00097","article-title":"Bone-targeted nanoplatform combining zoledronate and photothermal therapy to treat breast cancer bone metastasis","volume":"13","author":"Sun W","year":"2019","unstructured":"Sun W , Ge K , Jin Y , Han Y , Zhang H , Zhou G , Yang X , Liu D , Liu H , Liang XJ , et al. Bone-targeted nanoplatform combining zoledronate and photothermal therapy to treat breast cancer bone metastasis. ACS Nano. 2019;13(7):7556\u20137567.","journal-title":"ACS Nano"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.824117","article-title":"Roles of the RANKL-RANK axis in immunity\u2014Implications for pathogenesis and treatment of bone metastasis","volume":"13","author":"Li B","year":"2022","unstructured":"Li B , Wang P , Jiao J , Wei H , Xu W , Zhou P . Roles of the RANKL-RANK axis in immunity\u2014Implications for pathogenesis and treatment of bone metastasis. Front Immunol. 2022;13:Article 824117.","journal-title":"Front Immunol"},{"issue":"8","key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1007\/s12325-021-01812-9","article-title":"Bone health outcomes from the international, multicenter, randomized, phase 3, placebo-controlled D-CARE study assessing adjuvant denosumab in early breast cancer","volume":"38","author":"Coleman R","year":"2021","unstructured":"Coleman R , Zhou Y , Jandial D , Cadieux B , Chan A . Bone health outcomes from the international, multicenter, randomized, phase 3, placebo-controlled D-CARE study assessing adjuvant denosumab in early breast cancer. Adv Ther. 2021;38(8):4569\u20134580.","journal-title":"Adv Ther"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.227"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105163","article-title":"Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone","volume":"104","author":"Hodgson K","year":"2024","unstructured":"Hodgson K , Orozco-Moreno M , Goode EA , Fisher M , Garnham R , Beatson R , Turner H , Livermore K , Zhou Y , Wilson L , et al. Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone. EBioMedicine. 2024;104:Article 105163.","journal-title":"EBioMedicine"},{"issue":"2","key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0093-7754(01)90260-X","article-title":"The role of zoledronic acid in cancer: Clinical studies in the treatment and prevention of bone metastases","volume":"28","author":"Coleman RE","year":"2001","unstructured":"Coleman RE , Seaman JJ . The role of zoledronic acid in cancer: Clinical studies in the treatment and prevention of bone metastases. Semin Oncol. 2001;28(2 Suppl 6):11\u201316.","journal-title":"Semin Oncol"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2010.134"},{"issue":"6","key":"e_1_3_4_14_2","first-page":"570","article-title":"The vicious cycle of bone metastases","volume":"2","author":"Guise TA","year":"2002","unstructured":"Guise TA . The vicious cycle of bone metastases. J Musculoskelet Neuronal Interact. 2002;2(6):570\u2013572.","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00012.2019"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.855609","article-title":"The signaling pathways associated with breast cancer bone metastasis","volume":"12","author":"Song X","year":"2022","unstructured":"Song X , Wei C , Li X . The signaling pathways associated with breast cancer bone metastasis. Front Oncol. 2022;12: Article 855609.","journal-title":"Front Oncol"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fendo.2018.00313","article-title":"Role of tumor-derived chemokines in osteolytic bone metastasis","volume":"9","author":"Coniglio SJ","year":"2018","unstructured":"Coniglio SJ . Role of tumor-derived chemokines in osteolytic bone metastasis. Front Endocrinol. 2018;9:313.","journal-title":"Front Endocrinol"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra030831"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fcell.2020.00076","article-title":"RANKL\/RANK system-based mechanism for breast cancer bone metastasis and related therapeutic strategies","volume":"8","author":"Wu X","year":"2020","unstructured":"Wu X , Li F , Dang L , Liang C , Lu A , Zhang G . RANKL\/RANK system-based mechanism for breast cancer bone metastasis and related therapeutic strategies. Front Cell Dev Biol. 2020;8:76.","journal-title":"Front Cell Dev Biol"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111959","article-title":"Ononin triggers ferroptosis-mediated disruption in the triple negative breast cancer both in\u00a0vitro and in\u00a0vivo","volume":"132","author":"Gong G","year":"2024","unstructured":"Gong G , Wan Y , Liu Y , Zhang Z , Zheng Y . Ononin triggers ferroptosis-mediated disruption in the triple negative breast cancer both in\u00a0vitro and in\u00a0vivo. Int Immunopharmacol. 2024;132:Article 111959.","journal-title":"Int Immunopharmacol"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.714322","article-title":"Standardized Astragalus mongholicus Bunge-Curcuma aromatica Salisb. Extract efficiently suppresses colon cancer progression through gut microbiota modification in CT26-bearing mice","volume":"12","author":"Gu J","year":"2021","unstructured":"Gu J , Sun R , Wang Q , Liu F , Tang D , Chang X . Standardized Astragalus mongholicus Bunge-Curcuma aromatica Salisb. Extract efficiently suppresses colon cancer progression through gut microbiota modification in CT26-bearing mice. Front Pharmacol. 2021;12:Article 714322.","journal-title":"Front Pharmacol"},{"issue":"11","key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1021\/acs.jafc.8b00035","article-title":"Pharmacokinetics and bioavailability of the isoflavones formononetin and ononin and their in\u00a0vitro absorption in Ussing chamber and Caco-2 cell models","volume":"66","author":"Luo LY","year":"2018","unstructured":"Luo LY , Fan MX , Zhao HY , Li MX , Wu X , Gao WY . Pharmacokinetics and bioavailability of the isoflavones formononetin and ononin and their in\u00a0vitro absorption in Ussing chamber and Caco-2 cell models. J Agric Food Chem. 2018;66(11):2917\u20132924.","journal-title":"J Agric Food Chem"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.939646","article-title":"Ononin shows anticancer activity against laryngeal cancer via the inhibition of ERK\/JNK\/p38 signaling pathway","volume":"12","author":"Ye B","year":"2022","unstructured":"Ye B , Ma J , Li Z , Li Y , Han X . Ononin shows anticancer activity against laryngeal cancer via the inhibition of ERK\/JNK\/p38 signaling pathway. Front Oncol. 2022;12: Article 939646.","journal-title":"Front Oncol"},{"issue":"6","key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3390\/ph15060699","article-title":"In vitro evaluation of the antioxidant activity and chemopreventive potential in human breast cancer cell lines of the standardized extract obtained from the aerial parts of zigzag clover (Trifolium medium L.)","volume":"15","author":"Zg\u00f3rka G","year":"2022","unstructured":"Zg\u00f3rka G , Maciejewska-Turska M , Makuch-Kocka A , Plech T . In vitro evaluation of the antioxidant activity and chemopreventive potential in human breast cancer cell lines of the standardized extract obtained from the aerial parts of zigzag clover (Trifolium medium L.). Pharmaceuticals. 2022;15(6):699.","journal-title":"Pharmaceuticals"},{"issue":"1","key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12906-018-2148-2","article-title":"Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K\/AKT\/mTOR signaling pathway","volume":"18","author":"Zhou R","year":"2018","unstructured":"Zhou R , Chen H , Chen J , Chen X , Wen Y , Xu L . Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K\/AKT\/mTOR signaling pathway. BMC Complement Altern Med. 2018;18(1):83.","journal-title":"BMC Complement Altern Med"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"5122448","DOI":"10.1155\/2022\/5122448","article-title":"Antitumor effects of ononin by modulation of apoptosis in non-small-cell lung cancer through inhibiting PI3K\/Akt\/mTOR pathway","volume":"2022","author":"Gong G","year":"2022","unstructured":"Gong G , Ganesan K , Xiong Q , Zheng Y . Antitumor effects of ononin by modulation of apoptosis in non-small-cell lung cancer through inhibiting PI3K\/Akt\/mTOR pathway. Oxidative Med Cell Longev. 2022;2022:5122448.","journal-title":"Oxidative Med Cell Longev"},{"issue":"42","key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"24471","DOI":"10.1039\/C9RA04701H","article-title":"Astragali radix total flavonoid synergizes cisplatin to inhibit proliferation and enhances the chemosensitivity of laryngeal squamous cell carcinoma","volume":"9","author":"Cui J","year":"2019","unstructured":"Cui J , Zheng X , Yang D , Hu Y , An C , Bo Y , Li H , Zhang Y , Niu M , Xue X , et al. Astragali radix total flavonoid synergizes cisplatin to inhibit proliferation and enhances the chemosensitivity of laryngeal squamous cell carcinoma. RSC Adv. 2019;9(42):24471\u201324482.","journal-title":"RSC Adv"},{"issue":"6","key":"e_1_3_4_28_2","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23735","article-title":"Ononin: A comprehensive review of anticancer potential of natural isoflavone glycoside","volume":"38","author":"Sharma U","year":"2024","unstructured":"Sharma U , Sharma B , Mishra A , Sahu A , Mathkor DM , Haque S , Raina D , Ramniwas S , Gupta M , Tuli HS . Ononin: A comprehensive review of anticancer potential of natural isoflavone glycoside. J Biochem Mol Toxicol. 2024;38(6): Article e23735.","journal-title":"J Biochem Mol Toxicol"},{"issue":"9","key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s11427-023-2499-2","article-title":"Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K\/Akt\/mTOR pathway","volume":"67","author":"Ganesan K","year":"2024","unstructured":"Ganesan K , Xu C , Wu J , du B , Liu Q , Sui Y , Song C , Zhang J , Tang H , Chen J . Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K\/Akt\/mTOR pathway. Sci China Life Sci. 2024;67(9):1849\u20131866.","journal-title":"Sci China Life Sci"},{"issue":"7","key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"11969","DOI":"10.1002\/jcp.27852","article-title":"Evaluation of efficacy on RANKL induced osteoclast from RAW264.7 cells","volume":"234","author":"Song C","year":"2019","unstructured":"Song C , Yang X , Lei Y , Zhang Z , Smith W , Yan J , Kong L . Evaluation of efficacy on RANKL induced osteoclast from RAW264.7 cells. J Cell Physiol. 2019;234(7):11969\u201311975.","journal-title":"J Cell Physiol"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.950122","article-title":"Monascin abrogates RANKL-mediated osteoclastogenesis in RAW264.7 cells via regulating MAPKs signaling pathways","volume":"13","author":"Cheng Y","year":"2022","unstructured":"Cheng Y , Liu H , Li J , Ma Y , Song C , Wang Y , Li P , Chen Y , Zhang Z . Monascin abrogates RANKL-mediated osteoclastogenesis in RAW264.7 cells via regulating MAPKs signaling pathways. Front Pharmacol. 2022;13:Article 950122.","journal-title":"Front Pharmacol"},{"issue":"10","key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1111\/jcmm.16390","article-title":"Cell cytoskeleton and proliferation study for the RANKL-induced RAW264.7 differentiation","volume":"25","author":"Kong L","year":"2021","unstructured":"Kong L , Ma R , Cao Y , Smith W , Liu Y , Yang X , Yan L . Cell cytoskeleton and proliferation study for the RANKL-induced RAW264.7 differentiation. J Cell Mol Med. 2021;25(10): 4649\u20134657.","journal-title":"J Cell Mol Med"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2023.106440","article-title":"Progestins and breast cancer hallmarks: The role of the ERK1\/2 and JNK pathways in estrogen receptor positive breast cancer cells","volume":"237","author":"Louw-du Toit R","year":"2023","unstructured":"Louw-du Toit R , Simons M , Africander D . Progestins and breast cancer hallmarks: The role of the ERK1\/2 and JNK pathways in estrogen receptor positive breast cancer cells. J Steroid Biochem Mol Biol. 2023;237:Article 106440.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"e_1_3_4_34_2","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809003","article-title":"Stress signaling in breast cancer cells induces matrix components that promote chemoresistant metastasis","volume":"10","author":"Insua-Rodr\u00edguez J","year":"2018","unstructured":"Insua-Rodr\u00edguez J , Pein M , Hongu T , Meier J , Descot A , Lowy CM , de Braekeleer E , Sinn HP , Spaich S , S\u00fctterlin M , et al. Stress signaling in breast cancer cells induces matrix components that promote chemoresistant metastasis. EMBO Mol Med. 2018;10(10):Article e9003.","journal-title":"EMBO Mol Med"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2018.12.001"},{"issue":"4","key":"e_1_3_4_36_2","first-page":"701","article-title":"Gene regulation by phorbol 12-myristate 13-acetate in MCF-7 and MDA-MB-231, two breast cancer cell lines exhibiting highly different phenotypes","volume":"12","author":"Lacroix M","year":"2004","unstructured":"Lacroix M , Haibe-Kains B , Hennuy B , Laes J , Lallemand F , Gonze I , Cardoso F , Piccart M , Leclercq G , Sotiriou C . Gene regulation by phorbol 12-myristate 13-acetate in MCF-7 and MDA-MB-231, two breast cancer cell lines exhibiting highly different phenotypes. Oncol Rep. 2004;12(4):701\u2013707.","journal-title":"Oncol Rep"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.08.012"},{"issue":"2","key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.32604\/or.2023.046582","article-title":"Circular RNAs in breast cancer diagnosis, treatment and prognosis","volume":"32","author":"Huang X","year":"2023","unstructured":"Huang X , Song C , Zhang J , Zhu L , Tang H . Circular RNAs in breast cancer diagnosis, treatment and prognosis. Oncol Res. 2023;32(2):241\u2013249.","journal-title":"Oncol Res"},{"issue":"2","key":"e_1_3_4_39_2","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144579","article-title":"RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis","volume":"132","author":"Yue Z","year":"2022","unstructured":"Yue Z , Niu X , Yuan Z , Qin Q , Jiang W , He L , Gao J , Ding Y , Liu Y , Xu Z , et al. RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis. J Clin Invest. 2022;132(2):Article e144579.","journal-title":"J Clin Invest"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.34133\/research.0289"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01805-y"},{"issue":"1","key":"e_1_3_4_42_2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13578-023-01171-8","article-title":"Predictive and prognostic biomarkers of bone metastasis in breast cancer: Current status and future directions","volume":"13","author":"Wang S","year":"2023","unstructured":"Wang S , Wu W , Lin X , Zhang KM , Wu QL , Luo M , Zhou J . Predictive and prognostic biomarkers of bone metastasis in breast cancer: Current status and future directions. Cell Biosci. 2023;13(1):224.","journal-title":"Cell Biosci"},{"issue":"6","key":"e_1_3_4_43_2","first-page":"3599","article-title":"Baicalin inhibits the metastasis of highly aggressive breast cancer cells by reversing epithelial-to-mesenchymal transition by targeting \u03b2-catenin signaling","volume":"38","author":"Zhou T","year":"2017","unstructured":"Zhou T , Zhang A , Kuang G , Gong X , Jiang R , Lin D , Li J , Li H , Zhang X , Wan J , et al. Baicalin inhibits the metastasis of highly aggressive breast cancer cells by reversing epithelial-to-mesenchymal transition by targeting \u03b2-catenin signaling. Oncol Rep. 2017;38(6):3599\u20133607.","journal-title":"Oncol Rep"},{"issue":"3","key":"e_1_3_4_44_2","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3390\/ijms25031848","article-title":"Targeting PI3K\/AKT\/mTOR and MAPK signaling pathways in gastric cancer","volume":"25","author":"Morgos DT","year":"2024","unstructured":"Morgos DT , Stefani C , Miricescu D , Greabu M , Stanciu S , Nica S , Stanescu-Spinu II , Balan DG , Balcangiu-Stroescu AE , Coculescu EC , et al. Targeting PI3K\/AKT\/mTOR and MAPK signaling pathways in gastric cancer. Int J Mol Sci. 2024;25(3):1848.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"e_1_3_4_45_2","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1158\/0008-5472.CAN-23-1200","article-title":"Tumor cell-intrinsic p38 MAPK signaling promotes IL1\u03b1-mediated stromal inflammation and therapeutic resistance in pancreatic cancer","volume":"84","author":"Singh SP","year":"2024","unstructured":"Singh SP , Dosch AR , Mehra S , de Castro Silva I , Bianchi A , Garrido VT , Zhou Z , Adams A , Amirian H , Box EW , et al. Tumor cell-intrinsic p38 MAPK signaling promotes IL1\u03b1-mediated stromal inflammation and therapeutic resistance in pancreatic cancer. Cancer Res. 2024;84(8):1320\u20131332.","journal-title":"Cancer Res"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-2945"},{"issue":"29","key":"e_1_3_4_47_2","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2320709121","article-title":"STING trafficking activates MAPK-CREB signaling to trigger regulatory T cell differentiation","volume":"121","author":"Lin W","year":"2024","unstructured":"Lin W , Szabo C , Liu T , Tao H , Wu X , Wu J . STING trafficking activates MAPK-CREB signaling to trigger regulatory T cell differentiation. Proc Natl Acad Sci USA. 2024;121(29): Article e2320709121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01658"},{"issue":"2","key":"e_1_3_4_49_2","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s11033-020-06128-5","article-title":"Signaling pathways in human osteoclasts differentiation: ERK1\/2 as a key player","volume":"48","author":"Pennanen P","year":"2021","unstructured":"Pennanen P , Kallionp\u00e4\u00e4 RA , Peltonen S , Nissinen L , K\u00e4h\u00e4ri VM , Heerv\u00e4 E , Peltonen J . Signaling pathways in human osteoclasts differentiation: ERK1\/2 as a key player. Mol Biol Rep. 2021;48(2):1243\u20131254.","journal-title":"Mol Biol Rep"},{"issue":"10","key":"e_1_3_4_50_2","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/jcb.30076","article-title":"Inhibition of NFAM1 suppresses phospho-SAPK\/JNK signaling during osteoclast differentiation and bone resorption","volume":"122","author":"Ethiraj P","year":"2021","unstructured":"Ethiraj P , Haque IA , Alford AK , Gou W , Singh T , Sambandam Y , Hathaway-Schrader JD , Reddy SV . Inhibition of NFAM1 suppresses phospho-SAPK\/JNK signaling during osteoclast differentiation and bone resorption. J Cell Biochem. 2021;122(10):1534\u20131543.","journal-title":"J Cell Biochem"},{"key":"e_1_3_4_51_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216508","article-title":"A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer","volume":"581","author":"Wu S","year":"2024","unstructured":"Wu S , Lu J , Zhu H , Wu F , Mo Y , Xie L , Song C , Liu L , Xie X , Li Y , et al. A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer. Cancer Lett. 2024;581:Article 216508.","journal-title":"Cancer Lett"},{"issue":"1","key":"e_1_3_4_52_2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/14756366.2020.1720013","article-title":"Selective inhibitors for JNK signalling: A potential targeted therapy in cancer","volume":"35","author":"Wu Q","year":"2020","unstructured":"Wu Q , Wu W , Jacevic V , Franca TCC , Wang X , Kuca K . Selective inhibitors for JNK signalling: A potential targeted therapy in cancer. J Enzyme Inhib Med Chem. 2020;35(1): 574\u2013583.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.12.005"},{"issue":"2","key":"e_1_3_4_54_2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3892\/ijmm.2020.4820","article-title":"Melatonin inhibits RANKL-induced osteoclastogenesis through the miR-882\/Rev-erb\u03b1 axis in Raw264.7 cells","volume":"47","author":"Tian Y","year":"2021","unstructured":"Tian Y , Gong Z , Zhao R , Zhu Y . Melatonin inhibits RANKL-induced osteoclastogenesis through the miR-882\/Rev-erb\u03b1 axis in Raw264.7 cells. Int J Mol Med. 2021;47(2): 633\u2013642.","journal-title":"Int J Mol Med"},{"key":"e_1_3_4_55_2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.618411","article-title":"Advances in oral drug delivery","volume":"12","author":"Alqahtani MS","year":"2021","unstructured":"Alqahtani MS , Kazi M , Alsenaidy MA , Ahmad MZ . Advances in oral drug delivery. Front Pharmacol. 2021;12: Article 618411.","journal-title":"Front Pharmacol"},{"issue":"8","key":"e_1_3_4_56_2","first-page":"439","article-title":"Potential use of common administration of emulsion for parenteral nutrition and vinpocetine: Compatibility study and prospect","volume":"14","author":"Tomczak S","year":"2024","unstructured":"Tomczak S , Kaszuba K , Szkudlarek J , Piwowarczyk L , Jeli\u0144ska A . Potential use of common administration of emulsion for parenteral nutrition and vinpocetine: Compatibility study and prospect. Meta. 2024;14(8):439.","journal-title":"Meta"},{"issue":"4","key":"e_1_3_4_57_2","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1172\/JCI71812","article-title":"DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis","volume":"124","author":"Wang Y","year":"2014","unstructured":"Wang Y , Lei R , Zhuang X , Zhang N , Pan H , Li G , Hu J , Pan X , Tao Q , Fu D , et al. DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis. J Clin Invest. 2014;124(4):1646\u20131659.","journal-title":"J Clin Invest"}],"container-title":["Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.34133\/research.0553","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T14:54:19Z","timestamp":1757948059000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.34133\/research.0553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":56,"alternative-id":["10.34133\/research.0553"],"URL":"https:\/\/doi.org\/10.34133\/research.0553","relation":{},"ISSN":["2639-5274"],"issn-type":[{"value":"2639-5274","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2024-09-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"0553"}}